Contract facts
FederalNo full NAICS 611430 intel page yet. Browse NAICS intelligence
COLORETCAL CANCER SCREENINGS is a federal award for Cdc Office Of Acquisition Services held by Webmd Health Corp. Estimated value $424K ($20K obligated). Current period of performance ends Aug 29, 2022. Last award drew 2 bidders. Place of performance: NEW YORK NY.
Recompete timing
PublicCurrent PoP ended Aug 29, 2022 (1453 days ago). The usual 12–18 month agency planning window is closed — recompete action looks late / overdue relative to a normal cycle. Watch for bridge orders, follow-ons, or a new solicitation.
Incumbent footprint
Public recordWebmd Health Corp — $7.0M obligated across 33 awards (firm-wide, all agencies).
Query this award live in SCOUT via MCP — personalized scoring, watchlists, and capture workflow across the corpus. Learn about SCOUT MCP →
Frequently asked questions
What is contract 75D30119F06424?
75D30119F06424 (Coloretcal CANCER screenings) is a Cdc Office Of Acquisition Services award with a potential value of $424K, currently held by Webmd Health Corp. Figures are USASpending-sourced public-record facts plus SCOUT recompete analysis.
Which office awarded 75D30119F06424?
Cdc Office Of Acquisition Services awarded 75D30119F06424 to Webmd Health Corp (potential $424K).
Who is the incumbent on 75D30119F06424?
Webmd Health Corp is the incumbent with $7.0M across 33 related awards in SCOUT’s public footprint. The current period of performance ends Aug 29, 2022.
When does Webmd Health Corp’s 75D30119F06424 come up for recompete?
SCOUT tracks a period-of-performance end of Aug 29, 2022. Actual solicitation timing can shift with extensions, bridges, or consolidations.
Data: Showing contracts ≥ $100K from federal procurement records (FPDS-NG, SAM.gov, and related repositories), normalized by PrimeRFP SCOUT. Each row keyed by Award ID (PIID); task orders appear as independent rows.